Iovance Biotherapeutics, Inc. IOVA Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Iovance Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s earnings yield?
- Iovance Biotherapeutics, Inc. (IOVA) reported earnings yield of -24.5% in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s earnings yield changed year-over-year?
- Iovance Biotherapeutics, Inc.'s earnings yield increased by 28.8% year-over-year, from -34.4% to -24.5%.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s earnings yield?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s earnings yield has grown at a 56.9% compound annual growth rate (CAGR), from -3.8% to -36.1%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.